Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Gastroenterology. 2014 Jul 16;147(4):870–881.e8. doi: 10.1053/j.gastro.2014.07.005

Figure 2. Higher proliferative capacity of HCV-specific CD4 and CD8 T cells from SR/SR patients as compared to SR/CI patients.

Figure 2

Proliferation of HCV-specific T cells in a 6-day CFSE proliferation assay against overlapping peptide pools spanning the HCV proteins indicated. Representative proliferation data for CD4 T cells from two SR/SR (A) and two SR/CI (B) patients. Representative proliferation data for CD8 T cells from two SR/SR (C) and two SR/CI (D) patients. Proliferating cells were identified as percent viable CFSElo, CD4+ or CD8+, CD3+ T cells and presented as stimulation index (SI).